Publication | Open Access
Molecular determinants of ligand efficacy and potency in GPCR signaling
40
Citations
45
References
2023
Year
Drug TargetMolecular BiologyPeptide ScienceLigand EfficacySystems PharmacologyMolecular PharmacologySignaling PathwayCell SignalingAllosteric CompoundsMolecular PhysiologyData Science FrameworkBiochemistryMolecular PathwayMedicineG Protein-coupled ReceptorReceptor (Biochemistry)PharmacologyMolecular ModelingBiomolecular EngineeringSignal TransductionFunctional SelectivityNatural SciencesStructural ChangesSystems BiologyMolecular DockingSmall MoleculesDrug Discovery
Heterotrimeric guanine nucleotide-binding protein (G protein)-coupled receptors (GPCRs) bind to extracellular ligands and drugs and modulate intracellular responses through conformational changes. Despite their importance as drug targets, the molecular origins of pharmacological properties such as efficacy (maximum signaling response) and potency (the ligand concentration at half-maximal response) remain poorly understood for any ligand-receptor-signaling system. We used the prototypical adrenaline-β2 adrenergic receptor-G protein system to reveal how specific receptor residues decode and translate the information encoded in a ligand to mediate a signaling response. We present a data science framework to integrate pharmacological and structural data to uncover structural changes and allosteric networks relevant for ligand pharmacology. These methods can be tailored to study any ligand-receptor-signaling system, and the principles open possibilities for designing orthosteric and allosteric compounds with defined signaling properties.
| Year | Citations | |
|---|---|---|
Page 1
Page 1